Up-regulation of adipogenesis in adipocytes expressing stably cyclooxygenase-2 in the antisense direction

Prostaglandins and Other Lipid Mediators

Volumn 91, Issue 1-2, 2010, Pages 1-9

  Chu, Xiaoqing ^a   Nishimura, Kohji ^a   Jisaka, Mitsuo ^a   Nagaya, Tsutomu ^a   Shono, Fumiaki ^b   Yokota, Kazushige ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Adipocyte; Antisense; Cyclooxygenase 2; Prostanoids; Stable transfection

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ISOENZYME; MESSENGER RNA; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME REPRESSION; EXPRESSION VECTOR; GENE EXPRESSION; LIPID STORAGE; MOLECULAR CLONING; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROADIPOCYTE; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; STABLE EXPRESSION; STABLE TRANSFECTION; STIMULUS RESPONSE; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CLONING, MOLECULAR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC VECTORS; HUMANS; LIPID METABOLISM; MICE; RNA, ANTISENSE; RNA, MESSENGER; TRANSFECTION;

EID: 74849132740     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2009.10.002     Document Type: Article

References (41)

1. Despres J.P., Moorjani S., Lupien P.J., Tremblay A., Nadeau A., and Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10 (1990) 497
2. Saltiel A.R., and Kahn C.R. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414 (2001) 799
3. Campfield L.A., Smith F.J., Guisez Y., Devos R., and Burn P. Recombinant mouse Ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269 (1995) 546
4. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 26 (2005) 439
5. 2+-elevating agent. J Biol Chem 267 (1992) 11092
6. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83 (1995) 803
7. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83 (1995) 813
8. Lu S., Nishimura K., Hossain M.A., Jisaka M., Nagaya T., and Yokota K. Regulation and role of arachidonate cascade during changes in life cycle of adipocytes. Appl Biochem Biotechnol 118 (2004) 133
9. 2 synthesized by adipocytes during maturation phase contributes to upregulation of fat storage. FEBS Lett 580 (2006) 6885
10. Tsuboi H., Sugimoto Y., Kainoh T., and Ichikawa A. Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation. Biochem Biophys Res Commun 322 (2004) 1066
11. Reginato M.J., Krakow S.L., Bailey S.T., and Lazar M.A. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor γ. J Biol Chem 273 (1998) 1855
12. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69 (2000) 145
13. Hyman B.T., Stoll L.L., and Spector A.A. Prostaglandin production by 3T3-L1 cells in culture. Biochim Biophys Acta 713 (1982) 375
14. 2α in response to phorbol 12-myristate 13-acetate and action of these prostanoids during life cycle of adipocytes. Biochim Biophys Acta 1761 (2006) 434
15. Yan H., Kermouni A., Abdel-Hafez M., and Lau D.C. Role of cyclooxygenase COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells. J Lipid Res 44 (2003) 424
16. Fajas L., Miard S., Briggs M.R., and Auwerx J. Selective cyclo-oxygenasse-2 inhibitors impair adipocyte differentiation trough inhibition of the clonal expansion phase. J Lipid Res 44 (2003) 1652
17. Pang L., Nie M., Corbett L., and Knox A.J. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors. J Immunol 170 (2003) 1043
18. Fain J.N., Ballou L.R., and Bahouth S.W. Obesity is induced in mice heterozygous for cyclooxygenase-2. Prostaglandins Other Lipid Mediat 65 (2001) 199
19. Chu X., Xu L., Nishimura K., et al. Suppression of adipogenesis program in cultured preadipocytes transfected stably with cyclooxygenase isoforms. Biochim Biophys Acta 1791 (2009) 273
20. Yokota K., Morishima T., Nagaya T., Jisaka M., and Takinami K. Modification of cultured Madin-Darby canine kidney cells with dietary unsaturated fatty acids and regulation of arachidonate cascade reaction. Biosci Biotechnol Biochem 60 (1996) 1096
21. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156
22. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.L. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265
23. Markwell M.A., Hass S.M., Toleret N.E., and Bieber L.I. Protein determination in membrane and lipoprotein samples: manual and automated procedures. Methods Enzymol 72 (1981) 296
24. Kuri-Harcuch W., and Green H. Adipose conversion of 3T3 cells depends on a serum factor. Proc Natl Acad Sci U S A 75 (1978) 6107
25. 2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J Biol Chem 274 (1999) 3103
26. Mandrup S., and Lane M.D. Regulating adipogenesis. J Biol Chem 272 (1997) 5367
27. Cornelius P., MacDougald O.A., and Lane M.D. Regulation of adipocyte development. Annu Rev Nutr 14 (1994) 99
28. Brun R.P., Kim J.B., Hu E., Altiok S., and Spiegelman B.M. Adipocyte differentiation: a transcriptional regulatory cascade. Curr Opin Cell Biol 8 (1996) 826
29. Gregoire F.M., Smas C.M., and Sul H.S. Understanding adipocyte differentiation. Physiol Rev 78 (1998) 782
30. Green H., and Kehinde O. An established preadipose cell line and its differentiation in culture II: factors affecting the adipose conversion. Cell 5 (1975) 19
31. Hyman B.T., Stoll L., and Spector A.A. Accumulation of (n-9)-eicosatrienoic acid in confluent 3T3-L1 and 3T3 cells. J Biol Chem 256 (1981) 8863
32. Petersen R.K., Jorgensen C., Rustan A.C., et al. Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases. J Lipid Res 44 (2003) 2320
33. Xu L., Miyoshi H., Nishimura K., Jisaka M., Nagaya T., and Yokota K. Gene expression of isoformic enzyme in arachidonate cyclooxygenase pathway and the regulation by tumor necrosis factor-α during life cycle of adipocytes. Prostaglandins Other Lipid Mediat 83 (2007) 213
34. 2α serve as an anti-apoptotic factor against apoptosis induced by tumor necrosis factor-α in mouse 3T3-L1 preadipocytes. Biosci Biotechnol Biochem 70 (2006) 2145
35. Izant J.G., and Weintraub H. Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA. Science 229 (1985) 345
36. Knecht D.A., and Loomis W.F. Antisense RNA inactivation of myosin heavy chain gene expression in Dictyostelium discoideum. Science 236 (1987) 1081
37. Reusch J.E., Colton L.A., and Klemm D.J. CREB activation induces adipogenesis in 3T3-L1 cells. Mol Cell Biol 20 (2000) 1008
38. Aubert J., Saint-Marc P., Belmonte N., Dani C., Negrel R., and Ailhaud G. Prostacyclin IP receptor up-regulates the early expression of C/EBPβ and C/EBPδ in preadipose cells. Mol Cell Endocrinol 160 (2000) 149
39. Kaestner K.H., Christy R.J., and Lane M.D. Mouse insulin-responsive glucose transporter gene: characterization of the gene and tans-activation by the CCAAT/enhancer binding protein. Proc Natl Acad Sci U S A 87 (1990) 251
40. Munroe D.G., Wang E.Y., MacIntyre J.P., et al. Novel intracellular signaling function of prostaglandin H synthase-1 in NF-κB activation. J Inflamm 45 (1995) 260
41. Ruan H., Hacohen N., Golub T.R., Parijs L.V., and Lodish H.F. Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-κB activation by TNFα in obligatory. Diabetes 51 (2002) 1319